These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7877194)

  • 1. Effects of captopril and nadolol on renal hemodynamics in patients with essential hypertension.
    Zhu ZH; An R; Zhang YX; Gong PL; Chen H; Zen FD
    J Tongji Med Univ; 1994; 14(1):45-8. PubMed ID: 7877194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effects of tertatolol and nadolol on systemic and renal hemodynamics in patients with essential hypertension.
    Degaute JP; Naeije R; Abramowicz M; Leeman M; Schoutens A; Prost JF
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):263S-268S. PubMed ID: 3415803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nadolol in essential hypertension: effect on ambulatory blood pressure, renal haemodynamics and cardiac function.
    Dupont AG; Vanderniepen P; Bossuyt AM; Jonckheer MH; Six RO
    Br J Clin Pharmacol; 1985 Aug; 20(2):93-9. PubMed ID: 2864051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential exercise effects of captopril and nadolol in patients with essential hypertension.
    Kostis JB; Shindler DM; Moreyra AE; Ruddy MC; Schneider S; Cosgrove N
    Angiology; 1992 Aug; 43(8):647-52. PubMed ID: 1632567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of renal hemodynamics in the antihypertensive effect of captopril.
    Ando K; Fujita T; Ito Y; Noda H; Yamashita K
    Am Heart J; 1986 Feb; 111(2):347-52. PubMed ID: 3511649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effects and regional blood flow distribution associated with angiotensin converting enzyme inhibition (captopril) in essential hypertension.
    Ventura HO; Frohlich ED; Messerli FH; Kobrin I; Kardon MB
    Am J Cardiol; 1985 Apr; 55(8):1023-6. PubMed ID: 2984914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of betaxolol and nadolol on renal function in essential hypertension.
    Bauer JH; Reams GP; Lau A
    Am J Kidney Dis; 1987 Aug; 10(2):109-12. PubMed ID: 3300292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nadolol on systemic and renal hemodynamics in patients with renoparenchymal hypertension and various degrees of renal function.
    Valvo E; Gammaro L; Bedogna V; Cavaggioni M; Tonon M; Lupo A; Loschiavo C; Tessitore N; Oldrizzi L; Rugiu G
    Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):202-6. PubMed ID: 3710633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurohumoral mechanisms regulating renal blood circulation in patients with hypertension undergoing captopril block of angiotensin-converting enzyme].
    Almazov VA; Ametov AS; Shliakhto EV; Dolgova IB; Pushkarev AA
    Ter Arkh; 1989; 61(8):13-5. PubMed ID: 2573961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between short-term renal haemodynamic effects of propranolol and nadolol in essential hypertension: a cross-over study.
    Danesh BJ; Brunton J; Sumner DJ
    Clin Sci (Lond); 1984 Aug; 67(2):243-8. PubMed ID: 6146425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodynamic and clinical effects of long-term treatment of essential hypertension with captopril.
    Ricciardelli B; Volpe M; Trimarco B; De Luca N; Cuocolo A; Sacca' L; Condorelli M
    Eur Heart J; 1983 Jul; 4(7):496-501. PubMed ID: 6414815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of captopril on renal functions, renal and portal hemodynamics in patients with cirrhosis.
    Tsai YT; Lin HC; Lee FY; Hou MC; Wang SS; Lee SD
    Proc Natl Sci Counc Repub China B; 1996 Apr; 20(2):44-50. PubMed ID: 8931343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nadolol treatment on renal and hepatic hemodynamics and function in cirrhotic patients with portal hypertension.
    Gatta A; Sacerdoti D; Merkel C; Milani L; Battaglia G; Zuin R
    Am Heart J; 1984 Oct; 108(4 Pt 2):1167-72. PubMed ID: 6148880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic and regional haemodynamic profile of captopril in conscious rabbits with bilateral cellophane perinephritis hypertension.
    Bolt GR; Saxena PR
    Clin Exp Pharmacol Physiol; 1985; 12(4):417-26. PubMed ID: 3912085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redistribution of cardiac output to the kidneys during oral nadolol administration.
    Textor SC; Fouad FM; Bravo EL; Tarazi RC; Vidt DG; Gifford RW
    N Engl J Med; 1982 Sep; 307(10):601-5. PubMed ID: 7110207
    [No Abstract]   [Full Text] [Related]  

  • 16. Regional hemodynamics following captopril therapy.
    Am J Med; 1984 May; 76(5B):1-119. PubMed ID: 6375359
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal hemodynamic effects of nonhypotensive doses of angiotensin-converting enzyme inhibitors in hypertension and heart failure rats.
    Nelissen-Vrancken HJ; Struijker-Boudier HA; Smits JF
    J Cardiovasc Pharmacol; 1992 Feb; 19(2):163-8. PubMed ID: 1376783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Captopril and renal function.
    Reubi FC
    Contrib Nephrol; 1984; 43():159-70. PubMed ID: 6386324
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of the antihypertensive and renal effects of tertatolol and nadolol in hypertensive patients with mild renal impairment.
    Fallo F; Gregianin M; Bui F; Macrì C; Folino P; Mantero F
    Eur J Clin Pharmacol; 1991; 40(3):309-11. PubMed ID: 1676368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of converting enzyme inhibitor on hepatic blood flow in man.
    Crossley IR; Bihari D; Gimson AE; Westaby D; Richardson PJ; Williams R
    Am J Med; 1984 May; 76(5B):62-5. PubMed ID: 6328986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.